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Edited by Veli-Pekka LehtoAbstract Opacities (cataracts) in the lens of the eye are a lead-
ing cause of preventable blindness. Aquaporins function as water
channels, and the C-terminus is postulated as a regulatory do-
main. The C-terminal domain of aquaporin 0 (AQP0) develops
numerous truncation sites during lens aging. The purpose of
the present experiment was to determine if the calcium-activated
protease m-calpain (EC 3.4.22.17) was responsible for truncation
of human AQP0. AQP0 was isolated from young human donors,
incubated with recombinant m-calpain, and the cleavage sites on
the released peptides were determined by on-line electrospray
ionization mass spectrometry. We found that four cleavage sites
on human AQP0 could be tentatively assigned to m-calpain. This
is the ﬁrst evidence for possible calpain activity in human lens.
Because the cause(s) of 17 other cleavage sites was unknown,
the data also suggested that other, as yet unknown, proteases
or non-enzymatic mechanisms are more active than calpain in
human lens.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Aquaporins in mammals comprise a group of more than 10
integral membrane proteins [1]. AQP0 is the most abundant
membrane protein in lens and is localized to diﬀerentiated ﬁber
cells [2]. AQP0 contains six transmembrane a-helical domains
with a short 9 amino acid N-terminus and a longer 39 amino
acid C-terminus extending into the cytoplasm. Aquaporins
function as water channels, and the C-terminus is postulated
as a regulatory domain. The C-terminal domain of AQP0
seems especially susceptible to post-translation modiﬁcations
including deamidation, racemization, phosphorylation, and
proteolysis. For example, at least 21 cleavage sites have been
reported on the C-terminus of AQP0 in aging human lens
[2,3] (summarized in Fig. 1).
Selenite nuclear cataract in the rat also showed, along with
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doi:10.1016/j.febslet.2005.11.004K238 [4]. This was also the major cleavage site produced when
puriﬁed rat AQP0 was incubated with the protease m-calpain.
m-Calpain is a member of a group of Ca2+ activated, intracel-
lular, cysteine proteases [5]. Lens calpains are active in a wide
variety of rodent cataracts [6–13]. Part of the mechanism for
selenite cataract was probably loss of water homeostasis due
to hydrolysis of AQP0 by m-calpain.
Testing the relevance of the calpain-cataract hypothesis in
human lens is important because the mechanism for senile cat-
aracts is unknown. Human lenses contain several types of
ubiquitous calpains (m- and u-calpains) as well as calpain iso-
forms derived from tissue-speciﬁc p94 calpain [14,15]. Further,
many human cataracts contain elevated calcium levels which
could activate calpains [16]. However, no typical calpain cleav-
age sites have been discovered in human lens crystallins, which
comprise the bulk of proteins in the lens.
We do not know if the numerous truncations observed on
human AQP0 are produced by calpains. The proteases or
non-enzymatic mechanisms causing the cleavage sites are diﬃ-
cult to determine because human lens proteins are extremely
long-lived and show no turnover during the lifetime of an indi-
vidual. Overtime, initial proteolytic sites on lens proteins
caused by a speciﬁc protease could be masked by other com-
peting proteases or non-enzymatic hydrolysis. The two major
cleavage sites at N246 and N259 are known to be sites for
non-enzymatic ring formation and deamidation (Fig. 1), which
can lead to spontaneous backbone cleavage [2]. The purpose of
the present experiment was to use cleavage site analysis to
determine if the naturally occurring cleavage sites observed
on AQP0 from human lenses were caused by calpain.2. Methods
Isolation of AQP0 from human lenses. Human lenses at 1–4 days of
age were obtained with informed consent following the Tenets of the
Declaration of Helsinki. Decapsulated lenses were homogenized at a
ratio of 1 ml homogenizing buﬀer (20 mM phosphate, 1.0 mM EGTA,
pH 7.0) per lens. The insoluble pellet was obtained by centrifugation at
20000 · g for 30 min at 4 C and washed by resuspending each pellet
from one lens in 1.0 ml homogenizing buﬀer containing 50 mM
DTT. After centrifugation, each pellet was resuspended by vortexing
and brief sonication in 0.5 ml freshly made 7 M urea in homogenizing
buﬀer without DTT and spun down as before. Ice cold 0.1 N NaOH
with 1 mM DTT (0.5 ml) was added to the pellet and vortexed brieﬂy
to resuspended. After storage on ice for 15 min, the pellet was spun
down as before. The supernatant was carefully removed without dis-
turbing the pellet, which was then resuspended in 250 ll homogenizing
buﬀer without DTT by sonicating brieﬂy to obtain a uniform suspen-
sion. Protein concentrations were determined using the BCA assay
(Pierce Biotechnology, Rockford, IL) with bovine serum albumin as
standard.blished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Diagram of the amino acid sequence in the C-terminus of human AQP0. Arrows from above indicate in vivo cleavage sites observed in
aging human lenses [2,3]. Arrows from below indicate the ﬁve in vitro calpain cleavage sites observed on AQP0 in the present studies after incubation
of partially puriﬁed human lens membrane proteins with puriﬁed m-calpain. Bold arrows indicate major sites. Dotted ovals indicate identical
cleavage sites. (B) Coomassie blue-stained SDS–PAGE of lens membrane proteins from human lenses 1–4 days of age incubated with puriﬁed,
recombinant m-calpain for 20 min in the absence (lane 2) or presence (lane 3) of 1 mM free calcium. (C) Reverse phase HPLC chromatogram and the
amino acid sequence of each major peak derived from mass spectrographic analysis of peptides released after incubation of human AQP0 with
puriﬁed m-calpain. Range of numbers above each peak correspond to the N- and C- terminal amino acids of each released peptide, which can be
located in (A). Peak numbers 1–7 are used for identiﬁcation (see Section 3). The ‘‘?’’ mark indicates an unidentiﬁed peak.
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texing in 20 mM Tris, pH 7.4, buﬀer with 1 mM EGTA. Recombinant
rat m-calpain (Calbiochem/EMD Biosciences Inc., San Diego, CA)
was added at a ratio of 0.8 units per 10 lg membrane proteins. After
a 20 min incubation with or without 1 mM free calcium, the reaction
was stopped by addition of excess EGTA. After centrifugation, pellets
were diluted in Laemmli buﬀer without heating, and SDS–PAGE was
performed with on 12% polyacrylamide gels using the Mops buﬀer sys-
tem (Invitrogen Corporation, Carlsbad, CA).
Mass spectroscopy and sequencing. C-terminal peptides released into
the supernatant were separated by reverse-phase HPLC on a
0.5 · 250 mm C18 column (SB-C18, Aglilent, Palo Alto, CA) and ana-
lyzed by on-line electrospray ionization mass spectrometry (ESI-MS)
using a model LCQ ion trap (ThermoFinnigan, San Jose, CA). Tan-
dem mass spectra of peptides were analyzed by Sequest software using
a no enzyme speciﬁcity search and human subset of the Swiss-Prot
database [17].3. Results
In vitro proteolysis produced by incubating m-calpain with
human AQP0 was visualized by SDS–PAGE (Fig. 1B). In
preparations without calcium, intact AQP0 was the major
band at 26 kDa (Fig. 1B, lane 2). Activation of m-calpain with
calcium caused almost total loss of the intact 26 kDa AQP0
band and formation of two major bands at 22 and 20 kDa
(lane 3). The released AQP0 fragments in the samples were
separated by reverse phase chromatography into seven major
peaks (Fig. 1C). LC–MS analysis of the peptides in the peaks
identiﬁed ﬁve cleavage sites, which are located in Fig. 1A (lower
arrows):
Peaks 1, 2 and 3: T260 cleavage site. These peaks showed the
most intense ion currents, and all three peptides contained new
C-termini at T260. This cleavage site has also been observed in
minor amounts in normal middle-aged human lenses [2]
(Fig. 1A, upper arrow). These data suggested that cleavageat T260 in AQP0 could be caused by activation of m-calpain
in human lens, but that this activity occurred only to a minor
extent during normal aging.
Peak 4: N259 cleavage site. This site was previously identiﬁed
as a major cleavage site on AQP0 from aging human lenses [2].
Asparagine-259 undergoes, non-enzymatic deamidation, lead-
ing to ring formation and spontaneous cleavage. Residue 259
in AQP0 from rats is a lysine instead of asparagine, and incu-
bation with m-calpain also cleaves at the K259 site [4]. Thus, a
proportion of the proteolysis at this site could be due to m-cal-
pain, but in long-lived human lenses, the major human cleav-
age at N259 was most likely due to non-enzymatic truncation.
Peaks 5, 4, 3, and 6: T252 cleavage site. The peaks contained
new N and C-termini consistent with m-calpain-induced prote-
olysis between T252 and G253. Minor amounts of this cleavage
site have been observed in AQP0 during normal aging of hu-
man lenses [3], indicating possible action of m-calpain.
Peaks 1, 5, and 7: K238 site. Previous studies [4] showed that
the K238 cleavage site was the dominant fragment produced by
action of m-calpain on rat AQP0, and production of cleavage
at this site was accelerated in the selenite-induced cataract in
rats. K238 is believed to be a major in vitro cleavage site pro-
duced by m-calpain on human AQP0. Cleavage at this site
has been observed at very low abundance in human lenses
(Dr. Kevin L. Schey. Medical University of South Carolina,
personnel communication).
Peak 2: L237 cleavage site. The L237 cleavage site has not
been described in aging human lens.4. Discussion
Normal aging in human lenses is associated with the forma-
tion of at least 21 cleavage sites on the 39 amino acid sequence
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dant truncations were at N246 and N259 [2,3]. The present
in vitro study attempted to determine which of the 21 sites
were produced by m-calpain.
We found that incubation of isolated human AQP0 with
puriﬁed m-calpain produced ﬁve truncations. The in vitro
truncation at L237 has not been described in human lenses.
The in vitro truncations at T260, T252, and K238 have been
observed in minor amounts in human lenses [2,3]. The ﬁfth
in vitro truncation site produced by a 20-min incubation
with m-calpain occurred at N259. This is also the most
prominent truncation observed in aging human lenses [2].
Over a 96-h incubation without m-calpain, approximately
1% of human AQP0 spontaneously truncated at N259 (2),
opening the possibility of slow non-enzymatic deamidation
and spontaneous truncation at this site in vivo. Our data
showed that m-calpain also rapidly produces the N259 trun-
cation in vitro and suggested that m-calpain could contrib-
ute to in vivo truncation if calcium levels were elevated in
the lens. Note that the other site for non-enzymatic deami-
dation and truncation at N246 was not produced in the cur-
rent studies where AQP0 was incubated with m-calpain. The
N246 is a major site of deamidation and truncation in aging
human lenses [2]. Since no peaks with this truncation site
were observed in the present studies, our data support the
idea that truncation at N246 in human AQP0 may be due
to deamidation and non-enzymatic cleavage and/or other
proteases. In summary, our data implicate m-calpain as a
potential contributing protease for 4 of 21 cleavage sites nat-
urally occurring during aging of human AQP0 (Fig. 1A,
dotted ovals). To our knowledge, these are the ﬁrst data
showing tentative calpain cleavage sites on a human lens
protein.
We do not know the truncation sites on human lenses
exposed to the high calcium concentrations found in cata-
racts [16]. Since calpains are activated by calcium, possibly
some of the other in vitro sites, such as the abundant
truncation at K238, might then be found in human
AQP0 from human cataracts. Alternatively, because of
the abundant levels of endogenous calpain inhibitor cal-
pastatin in human lenses, m-calpain activity might continue
to be suppressed even in cataracts. We recently found very
little proteolysis of crystallins in human lenses incubated in
calcium ionophore A231897 (Nakajima, E., Ma, H.,
Shearer, T.R. and Azuma, M., unpublished), supporting
the idea that calpain activity on AQP0 may be minimal
in human lenses even when lenticular calcium levels are
elevated.
Since our data do not explain the cause of truncations at
the other 17 sites observed on AQP0 during human aging,
our data provide deductive evidence for the activation of
other unknown proteases against AQP0. The lens contains
several other protease systems including: calcium-activated
transglutaminase [18], the caspase cascade [19], the proteo-
some complex [20], a trypsin-like protease [21], various pepti-
dases [22], and a membrane associated protease [23].
Understanding which proteases and non-enzymatic cleavage
mechanisms are responsible for cleavage of AQP0 in human
lens membranes will be a diﬃcult but important challenge.
It is important because the integrity of membranes in human
lens is related to nutrient regulation, and ultimately, suscepti-
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